Navigation Links
China's reliance on lower-paid contract nurses may compromise patient care
Date:1/29/2014

(NEW YORK, NY, January 29, 2014) Economic and health system reforms in China in recent decades have dramatically reduced the number of traditional hospital nursing jobs, known as "bianzhi" or "iron rice bowl" positions, which are guaranteed for life. Instead, more than half of nursing posts in many Chinese hospitals are now filled with contract-based nurses who do the same work as "bianzhi" for lower pay, fewer benefits and limited job security. A new study from Columbia University School of Nursing, published in the journal Human Resources for Health, found significantly higher levels of compensation-related dissatisfaction among contract nurses than their "bianzhi" peers. Hospitals with a disproportionate number of contract nurses also had significantly higher levels of patient dissatisfaction, which prior research has linked to lower quality care and worse outcomes.

A research team, led by Columbia Nursing Assistant Professor Jingjing Shang, PhD, RN, investigated the impact of inequitable nurse compensation on patient satisfaction at a representative cross section of 181 Chinese hospitals. The study found that hospitals where contract nurses reported high levels of dissatisfaction with their salary and benefits also had lower quality ratings and were less likely to be recommended by patients. The results suggest a need for more uniform compliance with the China Health Ministry's voluntary regulations requesting that hospitals eliminate two-tiered compensation systems for nurses, Shang says.

"For the best patient outcomes, we really need to have equal pay for equal work," says Shang. "The low rate of job satisfaction among contract nurses puts patients at risk."

Use of contract nurses is expected to increase as China continues its transition to a free market economy and demand for health care increases due to an aging population. The practice has also gained traction over the past decade amid a worsening nursing shortage in
'/>"/>

Contact: Lisa Rapaport
lr2692@cumc.columbia.edu
212-342-3795
Columbia University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Arizona State University secures defense contract
2. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
3. Local Woodinville Contractor, Washington State Kitchen and Bath, Combats Toxic Mold, Adhering to the Toughest Mold Protection Standards in the Nation with New Promotion
4. Collagenase for Dupuytrens contracture: Added benefit not proven
5. BMC awarded contract to study validity of primary care drug screening tools
6. Federal government renews contract for collecting and maintaining national stem cell transplantation database
7. NIH awards Georgia malaria research consortium up to $19.4 million contract
8. Care2Learn/Upstairs Solutions and Jarlette Health Services Sign Multi-Year Contract for Online Training and Record-Keeping
9. NHS consultant contract fails to increase productivity
10. PLEXERA® LLC Launches Contract Research Services Business for Biomolecular Interaction Studies
11. Securityhunter, Inc. Selected as a Top 25 Baltimore Defense Contractor for the Baltimore Business Journal's 2013 Book of Lists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... NY (PRWEB) March 05, 2015 Shania Twain ... in more than a decade. She has hinted that this ... to miss seeing her perform one last time. She has ... and this beloved country sweetheart has millions of loyal fans around ... throughout her native country, Canada, and on June 30th she will ...
(Date:3/5/2015)... 2015 This week, 60 ... low-cost laminate flooring products, initiating widespread concern from ... building materials made primarily from bamboo, stands behind ... their flooring products for volatile organic compounds (VOCs) ... International (BMH). Results from formaldehyde emissions testing ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned ... awarding the plaintiff Coleen M. Perry a total of $5.7 ... TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., a ... a partner at Wagstaff & Cartmell in Kansas ... along with Rich Freese and Tim Goss of Freese ...
(Date:3/5/2015)... 05, 2015 AxoGen, Inc. (NASDAQ: ... the peripheral nerve repair market, reported record revenue of ... 2014 compared to $2.98 million in the year-ago fourth ... strategies. , “Our strong fourth quarter revenue growth ... repair products which is driving increased surgeon adoption of ...
(Date:3/5/2015)... March 05, 2015 Risperdal lawsuits ... a Pennsylvania mass tort litigation currently underway in ... jury has begun hearing testimony in the proceeding’s ... antipsychotic medication can cause gynecomastia, or male breast ... question was filed on behalf of a plaintiff ...
Breaking Medicine News(10 mins):Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3
... CEO, Will Continue Serving as Chairman of the Board, ... Bulletin Board: MLSS), the recognized leader in,advanced injection technologies, ... Martin, Chief Executive Officer of the Company,s,medical division, as ... of its Board,of Directors, effective January 1, 2008. As ...
... Detection and treatment of tumours, diseased blood vessels and ... an innovative imaging system being developed that uses both ... extremely short pulses of low-energy laser light to stimulate ... area being examined. These waves are then converted into ...
... Amsterdam, December 12, 2007 Elsevier, a leading ... today announced that 45 French-language medical journals from ... January 3, 2008. , The titles, including Feuillets ... Mdicale, represent a wide range of high-quality journals ...
... by 81 percent of Michigan adults, DETROIT, Dec. ... of reform measures proposed in the Michigan Legislature,that would ... increases and set standard rating practices for all insurers ... made public today,by Blue Cross Blue Shield of Michigan., ...
... TITUSVILLE, N.J., Dec. 12 INVEGA(TM) (paliperidone),Extended-Release ... a one-year open-label extension (OLE) study, according ... symptom scores improved or,were stable, on average, ... was designed to evaluate the long-term safety ...
... it. Hair Fairies - The Head Lice, Helpers - is here to ... ... No two words in the English language,can stop every parent in ... other kid-centric services are often,sent into crisis mode when an outbreak occurs, ...
Cached Medicine News:Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 2Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 3Health News:Light and sound -- the way forward for better medical imaging 2Health News:ScienceDirect to host French-language journals from Elsevier Masson 2Health News:Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan 2Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 2Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 3Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 4Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 5Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 6Health News:Head Lice Removal Service Opens in Chicago 2Health News:Head Lice Removal Service Opens in Chicago 3
(Date:3/5/2015)... , March 5, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of targeted antiviral therapies, announced ... Annual ROTH Conference, to be held March 8-11, ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, announced today that ... top rehabilitation hospitals for spinal cord injury and brain ... trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured ... injury (SCI). The Phase 1/2a trial ...
(Date:3/5/2015)... and VANCOUVER, British Columbia ... BUX FSE: 20B OTCQB: BMKDF) -- The ultimate goal ... assay that is capable of detecting tumors before they ... years, the development of such an assay has been ... academia and industry. Although many breakthrough diagnostics have been ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization, today ... on June 23, 2010 , at the InterContinental Hotel in Boston . ... Kendle,s formal presentation will be given by Chairman ... Time . , , , ...
... June 17 Brainlab AG today announced that it ... business unit of the Toshiba Group, to integrate its Aquilion™ LB ... operating room (OR). , , ... Stephan Holl , Chief Operating Officer, Brainlab, indicated that ...
Cached Medicine Technology:Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference 2Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite 2Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite 3
... fixed-volume, adjustable-volume, and multichannel models as ... pro Pipette. Designed with a separate ... have earned a worldwide reputation for ... original Eppendorf pipette tips, they provide ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Research Family includes fixed-volume, adjustable-volume, and ... electronic Eppendorf Research pro Pipette. Designed ... compact, high-performance pipettes have earned a ... for use with original Eppendorf pipette ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: